Related Experiment Video
Updated: Jun 6, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Adjuvant therapy for melanoma: a surgical perspective
Vernon K Sondak1, Ricardo J Gonzalez, Ragini Kudchadkar
1Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA. vernon.sondak@moffitt.org
Surgical Oncology Clinics of North America
|November 30, 2010
Summary
Adjuvant therapy is crucial for melanoma patients post-surgery to prevent recurrence. This review details the benefits and risks of current and emerging melanoma treatments.
Area of Science:
- Oncology
- Dermatology
Background:
- Melanoma recurrence after surgery often leads to fatal outcomes.
- Surgeons play a key role in guiding patient decisions on adjuvant therapy.
- Understanding recurrence risks is vital for informed treatment choices.
Purpose of the Study:
- To review available and investigational adjuvant systemic therapies for melanoma.
- To summarize the oncologic benefits of these therapies.
- To outline the relevant toxicities associated with adjuvant melanoma treatments.
Main Methods:
- Literature review of adjuvant systemic therapies for melanoma.
- Analysis of oncologic outcomes and toxicity profiles.
- Synthesis of data on currently available and under-investigation treatments.
Main Results:
- Adjuvant therapies offer potential oncologic benefits in preventing melanoma recurrence.
- Various systemic treatments are available and under investigation.
- Each therapy presents a unique profile of potential benefits and toxicities.
Conclusions:
- Adjuvant systemic therapy is a critical component in managing melanoma post-surgery.
- Informed patient decisions require clear communication of recurrence risks and treatment profiles.
- Ongoing research is expanding therapeutic options for adjuvant melanoma treatment.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.